Clinical Trials Directory

Trials / Completed

CompletedNCT00763997

Study of the Effect of Dipyrone, Ibuprofen, Paracetamol and Parecoxib on the Platelet Aggregation in Analgetic Dosages

Study of the Effect of Dipyrone, Ibuprofen, Paracetamol and Parecoxib on the Platelet Aggregation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Ruhr University of Bochum · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Dipyrone is suggested to inhibit the platelet aggregation comparable to th effect of traditional analgetic substances like Ibuprofen. To verify this hypothesis the investigators conducted the study in comparing patients undergoing traumatologic, visceral or plastic surgical procedures. The investigators randomized them to four groups receiving common analgetic doses of either dipyrone, acetaminophen (paracetamol) or valdecoxib/parecoxib. The investigators took blood samples before initiation of the study drug, 1h, 4hs and 24hs after first intake. The investigators compared the aggregation via aggregometry of platelet rich plasma.

Conditions

Interventions

TypeNameDescription
DRUGdipyroneDipyrone is given in the operation room with 2,5 g intravenously, followed by an oral regime of 4x1g on the ward
DRUGIbuprofenIbuprofen is given orally 600mg in the Post Anesthesia Care Unit, followed by an oral regime of 800mg twice a day
DRUGAcetaminophenAcetaminophen is given 1g intravenously in the Operation room, followed by an oral regime of 1g fourth a day
DRUGAcetaminophenAcetaminophen is given 1g intravenously in the operation room, followed by 1g orally fourth a day
DRUGParecoxib/Valdecoxib40mg Parecoxib are given intravenously in the operation room, followed by 40mg of Valdecoxib orally twice a day
OTHERBlood samplesBlood samples for aggregometry are taken before induction of anesthesia, 1h after first drug intake, 4hs and 24hs after first intake

Timeline

Start date
2004-02-01
Primary completion
2004-12-01
Completion
2004-12-01
First posted
2008-10-01
Last updated
2008-10-01

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00763997. Inclusion in this directory is not an endorsement.